In this video, Dr. Nura Mohamed, research associate at Qatar University, discusses how she is applying nanomedicine to improve the detection and treatment strategy of pulmonary arterial hypertension. Mohamed explores the field of nanomedicine and highlights why scientific collaboration is necessary in order to identify appropriate nanoparticle properties. Mohamed also reveals how she characterizes and measures nanoparticle toxicity using both in vitro and in vivo models. Looking ahead, Mohamed shares her thoughts on the future of personalized medicine and targeted therapy, and reveals how nanomedicine could offer hope to patients suffering from rare disease.